AOB Enters Hong Kong Market As Company Receives License to Market 15 Products
HONG KONG, April 15, 2005 /PRNewswire-FirstCall via COMTEX/ -- America Oriental Bioengineering Inc., (AOBO), a rapidly growing Chinese company which produces and distributes a broad range of pharmaceutical and nutriceutical products, announced today that it has entered the Hong Kong market, and has granted import licenses for 15 out of 16 products that will be marketable in the territory by the Hong Kong Health Department. The Company has also succeeded in obtaining registered trademarks for 9 of its 11 products.
The Company has opened its first retail location, near The Time Square, the most popular shopping centre in Causeway Bay, Hong Kong. American Oriental has also entered into a distribution agreement with Mannings, one of the largest retail shops in Hong Kong. It expects that several of its leading products, including Soy Peptide Tablets, will be sold through the retail chain in the near future. The Company has developed special product packaging for the Hong Kong market designed to enhance the appeal of its products.
"We are excited to enter the lucrative Hong Long market," said Tony Liu, Chief Executive Officer of American Oriental. "We have developed the necessary infrastructure to support our growth there, developing the production, logistics and warehouse facilities to support a large sales operation. We believe that our success in this market will pave the way for us to enter additional markets throughout Asia."
About American Oriental Bioengineering, Inc. |
